Natural history and rate of progression of retinopathy in adult sickle cell disease patients: an 11-year follow-up study

Autor: Rajani Priya Brandsen, Roselie MH Diederen, Siham Bakhlakh, Erfan Nur, Reinier O Schlingemann, Bart J Biemond

Publikováno v: Blood Advances.

Sickle cell retinopathy (SCR) is a complication of sickle cell disease (SCD). Proliferative SCR (PSCR) can lead to severe visual impairment due to vitreous hemorrhage or retinal detachment. Knowledge of risk factors for progression and complications

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed6cd2b450b2d01abbd4dac1dd4df086
https://doi.org/10.1182/bloodadvances.2022009147

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Autor: Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink

Publikováno v: Rheumatic & Musculoskeletal Diseases Open, 8, 1
RMD open, 8(1):002035. BMJ Publishing Group
Rheumatic & Musculoskeletal Diseases Open, 8
RMD Open, 8(1):002035. BMJ Publishing Group
Boekel, L, Hooijberg, F, Vogelzang, E H, Besten, Y R, Leeuw, M, Atiqi, S, van Vollenhoven, R F, Wijbrandts, C A, Gerritsen, M, Krieckaert, C, Dijkshoorn, B, Bakhlakh, S, Crooijmans, J J, Voskuyl, A, van der Horst-Bruinsma, I E, Lems, W, Kuijpers, T W, van Ham, S M, Wieske, L, Eftimov, F, Kummer, L Y, van Dam, P K, Stalman, E W, Steenhuis, M, Keijzer, S, Cristianawati, O, Keijser, J, Loeff, F C, Tas, S W, Nurmohamed, M T, Boers, M, Rispens, T & Wolbink, G 2022, ' Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases : data from a prospective cohort study ', RMD Open, vol. 8, no. 1, 002035 . https://doi.org/10.1136/rmdopen-2021-002035

BackgroundResearch on the disease severity of COVID-19 in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term prospective data on the development of SARS-CoV-2 antibodies in these patients are la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1435379ab158ca7d4c0cf06c2e660c43